VacChina 2016

Exploring Big Opportunities for Vaccine Industry in China and Emerging Markets

China vaccine market expanded fast and has kept a leading growth during the past years. It is expected to reach more than 4 billion USD by 2016. Through multiple partnerships, a series of important novel vaccines including HFMD, Sabin IPV, HPV and EPV have been successfully developed. Besides, China is also embracing a gold period on therapeutic vaccine development. Following Chengdu Institute, Hualan has also got the approval of WHO PQ in early 2015. Leading companies like Sinovac, Zhifei Biotech are building their strategy for emerging markets. In order to become qualified international player, local companies are striving to upgrade manufacturing facilities and QMS, with unprecedented passion.

At the same time, animal vaccine industry also enjoys fast development during recent years. The mandated immune plan promotes the market expansion while the market-oriented vaccines become the main driver for industry growth. With an annual growth of 24%, the animal vaccine market will reach more than 2.5 b USD in 2016. The booming market encourages soaring investment on new production line both from local and international companies. Besides, technology transfer on novel vaccine development is still a key point for major companies to keep competitive in China. Leading companies like Jinyu are building facilities in Africa for international market expansion.

VacChina 2016, to be held on April 12-13, in Shanghai,China, is the largest international vaccine event in China,covering the entire value chain of the vaccine industry. Here, two parallel forums will be arranged on both human vaccine and animal vaccine, assessing the latest industrial trends, R&D progress, partnership opportunities and manufacturing technology advancements in China and Emerging markets. Meanwhile, Companies will also know the way to get into the emerging markets and build international partnership on vaccine development and commercialization as well.

Key issues for VacChina 2016

Human Vaccine Forum:

Supply and demand of Emerging vaccine markets

Building regional partnership to accelerate novel vaccine development

Successful R&D &Commercialization Strategy for vaccines

Integrating Chinese vaccine into global Market

Ebola/ MERS/HPV/RSV vaccine development update

Clinical strategies for Vaccines

Advanced technologies and strategies for excellent biomanufacturing

Adjuvant/Formulation technologies

Animal Vaccine Forum:

Strategies to development veterinary vaccine in China

Supply and demand of emerging vaccine markets

Technology transfer in global veterinary vaccine development

Catching big opportunities in global animal vaccine market through novel strategic partnership model

Regulatory Requirements for Conventional and Next Generation Veterinary Vaccines

Suspension culture and microcarrier culture techniques applied in animal vaccine manufacturing

Novel adjuvant technology in vaccine development

Recombined vaccine development

Part of Confirmed Speakers

Melissa Malhame, Head of Market Shaping, GAVI Alliance

Heather Deeham, Chief, Vaccine Centre, Supply Division, UNICEF

R.K. Suri, CEO, Biologicals, Panacea Biotec

Peter Khoury,Senior Program Officer, Life Sciences Partnerships - Developing Country Manufacturers, Bill & Melinda Gates Foundation

Yi Tang, EPI Officer, China, WHO

Jerome Kim, Director General, International Vaccine Institute

Sean Du, Head of External R&D, Asia Pacific, Sanofi Pasteur

Rodolfo Bellinzoni, chief operating officer , Biogénesis Bagó,Argentina

Christophe Derozier, Executive Director, animal medical R&D Center, Zoetis

Shoichiro Hirata, Overseas Operation Leader, Nisseiken, Japan

Xuefeng Yu, CEO, Cansino

Steven Gao, CEO, Innovax

Bin Wang, Professor, Fudan University

Yarong Zhao, VP, DBN Group

Tony D’amore, VP, Product Research and Development, Sanofi Pasteur

Shibo Jiang，Professor, Fudan University

Dexiang Chen, Technical Officer, PATH

Qihan Li, Director General, IMBCAMS (Kunming Institute)

K.Anand Kumar, Deputy Managing Director，Indian Immunologicals

Previous event review:

Supporters:

International Vaccine Institute

International Society for Vaccines

Taiwan Bio Industry Organization

China National Biotec Group(CNBG)

Organizer:

Shine Media International